CHICAGO/LONDON (Reuters) – When a newly organized vaccine research group at the U.S. National Institutes of Health (NIH) met for the first time this week, its members had expected to be able to ease into their work. But their mandate is to conduct human trials for emerging health threats – and their first assignment came at shocking speed.

 

iStock, MarianVejcik

Read more…